The genetic research Allows prediction of diseases because it detects the genetic data of humans. This data allows the doctor to choose the best treatment, the right dose with fewer side effects for the patient, thus achieving a more personalized drug.
This was explained by Dr. Heinner Guio, his investigator National Institute of Health (INS) and responsible for research on the peruvian genome. "In some countries the study of genetics in their populations has been able to detect the risk of developing hypertension.
Another example is the indication of risk reduction surgery (mastectomies) after finding pathogenic mutations of patients in genes related to breast cancer development, "he explained.
In Europe, this system has been established, benefiting from the results. In the case of Latin America, Mexico was the first country to report its results in 2009, Brazil in 2015, and Peru in 2018. "INS has identified about 3 million genetic variants that have never been reported. variations will be analyzed in the various medical specialties of Peru to confirm which of them could have clinical consequences.
There are currently many genetic tests for disease diagnosis. Our findings will help these trials to improve their prediction in our population, "Guio said in his research that the Peruvian mandate has 60% native composition.
"Many of the genetic variants we have found are present in native communities, so the population of Peru will benefit from these findings to improve disease risk detection," he explained.
The specialist will present his document on the Peruvian Human Genome at the XII International Scientific Conference of INS: Current Public Health Challenges in Peru, to be held from 06 to 08 November.